Asset Management One
PDSB icon

Asset Management One’s PDS Biotechnology PDSB Stock Holding History

Asset Management One’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,189
Closed -$2.31M – 1156
2016
Q3 		$2.31M Sell
11,189
-1,157
-9% -$229K 0.03% 561
2016
Q2 		$2.42M Sell
12,346
-677
-5% -$120K 0.04% 537
2016
Q1 		$2.47M Buy
13,023
+4
+0% +$715 0.04% 542
2015
Q4 		$3.35M Buy
+13,019
New +$4.2M 0.05% 434

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Asset Management One's PDSB Position: Q4 2016 in Review

Asset Management One sold out of PDS Biotechnology (PDSB) in Q4 2016, closing a stake of 11,189 shares — an estimated $2.31M sold.

Asset Management One first reported a position in PDSB in Q4 2015 and held it in 4 quarters. The position peaked at $3.35M in Q4 2015. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

  • Asset Management One reported no remaining PDS Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 11,189 PDS Biotechnology shares in Q4 2016, an estimated $2.31M.
  • Asset Management One first reported a position in PDS Biotechnology in Q4 2015 and held it in 4 quarters.
  • Asset Management One's PDS Biotechnology position peaked at $3.35M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.